Search
forLearn
5 / 801 resultslearn Shankh bhasm
learn Haritaki
learn Arjun
learn Bacopa monniera
Research
5 / 26 resultsresearch Pracchanna Karma Followed by Tikta Patola Patra Swarasa Lepa in Indralupta (Alopecia Areata): A Case Study
Ayurvedic treatment can effectively reduce symptoms of alopecia areata.
research A Comparative Study to Evaluate Efficacy of Prachanna Karma Followed by Chirabilva Lepa and Gunja Lepa in the Management of Indralupta w.s.r to Alopecia Areata
Prachanna followed by Chirabilwa lepa is more effective for alopecia areata than Prachanna followed by Gunja lepa.
research Integrative Ayurvedic management of Khalitya (Hair Fall) using Gunjadi Taila, Amalaki Rasayana, Arogya Vardhini Vati, Saptamruta Loha and Prachhanna Karma - A Case Report
An Ayurvedic treatment effectively reduced hair fall and improved scalp health.
research Holistic management of Alopecia areata (~Indralupta) using Pracchana karma with derma-roller and Ayurveda intervention: A case report
Ayurvedic treatment led to complete hair regrowth in a patient with Alopecia Areata.
research Role of Pracchana Karma followed by Bibhitaki Lepa in Indralupta (Alopecia Areata)
Ayurvedic treatments improved alopecia areata symptoms.
Community Join
5 / 1000+ resultscommunity Haircafe on why microneedling is bad for hair growth
Microneedling combined with minoxidil and finasteride shows significant hair regrowth, though opinions on its effectiveness vary. Some users report substantial benefits, while others highlight the need for more research and consistency in application.
community How’s RCH-01 doing?
RCH-01's progress is uncertain, and there's skepticism about its effectiveness. Users are losing hope in this treatment.
community Kintor Pharma Announced Successful Dosing of the First Patient for Acne Vulgaris Phase II Clinical Trial of KX-826
Kintor Pharma successfully dosed the first patient in a Phase II trial for KX-826 for acne vulgaris. Users are more interested in results for male pattern baldness (MPB).
community Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
Kintor Pharma has finished enrolling the first patient in a Phase III trial for KX-826, a treatment for androgenetic alopecia (AGA). One user has set a reminder to check back on the topic in a year.
community Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US_Kintor Pharmaceutical Limited
Kintor Pharma finished enrolling and dosing participants in a Phase I trial for a hair loss treatment called AR-PROTAC (GT20029). The effectiveness of another drug, pyrilutamide (KX-826), for hair loss will be clearer after a Phase 2 trial expected to complete in January 2023.